PEAK6 Group’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
$1.05M Buy
22,400
+13,400
+149% +$552K ﹤0.01% 1905
2018
Q1
$326K Buy
+9,000
New +$317K ﹤0.01% 2976
2017
Q4
Sell
-18,500
Closed -$709K 4673
2017
Q3
$709K Buy
+18,500
New +$775K ﹤0.01% 2257
2016
Q3
Sell
-10,700
Closed -$293K 4642
2016
Q2
$293K Buy
10,700
+2,700
+34% +$69K ﹤0.01% 2831
2016
Q1
$215K Buy
+8,000
New +$196K ﹤0.01% 3072
2015
Q4
Sell
-40,800
Closed -$1.14M 5202
2015
Q3
$1.14M Sell
40,800
-56,100
-58% -$2.03M 0.01% 2072
2015
Q2
$4M Buy
+96,900
New +$3.55M 0.02% 983

Other funds holding RGEN

PEAK6 Group's RGEN Position: Q4 2017 in Review

PEAK6 Group sold out of Repligen (RGEN) in Q4 2017, closing a stake of 12,922 shares — an estimated $495K sold.

PEAK6 Group first reported a position in RGEN in Q4 2015 and held it in 2 quarters. The position peaked at $495K in Q3 2017. 184 funds tracked by Wall St. Rank hold RGEN as of Q4 2017.

  • PEAK6 Group reported no remaining Repligen position as of Q4 2017 after selling out during the quarter.
  • PEAK6 Group sold 12,922 Repligen shares in Q4 2017, an estimated $495K.
  • PEAK6 Group first reported a position in Repligen in Q4 2015 and held it in 2 quarters.
  • PEAK6 Group's Repligen position peaked at $495K in Q3 2017.
  • 184 funds tracked by Wall St. Rank held Repligen as of Q4 2017.

Based on PEAK6 Group's 13F filing for Q4 2017, filed 14 Feb 2018.